• No se han encontrado resultados

Metastatic breast cancer

Metastatic breast cancer patients treated with low dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

Metastatic breast cancer patients treated with low dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

... were metastatic and heavily pretreated, it is not expected to obtain a high ...for metastatic breast cancer [23,24] but with the advantage of avoiding ...

25

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer.

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer.

... Circulating tumor cells (CTCs) are frequently associated with epithelial- mesenchymal transition (EMT).The objective of this study was to detect EMT phenotype through Vimentin (VIM) and Slug expression in cytokeratin ...

12

Radiotherapy for Metastatic Breast Cancer in Mexico: Results from the 2015 National Survey

Radiotherapy for Metastatic Breast Cancer in Mexico: Results from the 2015 National Survey

... in breast cancer ...for metastatic breast cancer in ...for metastatic breast cancer in ...with breast cancer in ...

9

A Randomized Trial of Combination Anastrozole plus Gefitinib and of Combination Fulvestrant plus Gefitinib in the Treatment of Postmenopausal Women with Hormone Receptor Positive Metastatic Breast Cancer

A Randomized Trial of Combination Anastrozole plus Gefitinib and of Combination Fulvestrant plus Gefitinib in the Treatment of Postmenopausal Women with Hormone Receptor Positive Metastatic Breast Cancer

... positive, metastatic breast cancer and yet traditional definitions of response exclude bone as a site of assessable ...in breast cancer predicts for disease-related outcomes similar to ...

8

Trastuzumab emtansina en carcinoma de mama HER2 positivo metastásico o localmente avanzado; informe de evaluación GENESIS-SEFH

Trastuzumab emtansina en carcinoma de mama HER2 positivo metastásico o localmente avanzado; informe de evaluación GENESIS-SEFH

... Metastatic breast cancer (MBC) is described as an invasive breast cancer that has spread beyond the breast and nearby lymph nodes to other organs such as the lungs, distant lymph ...

5

Intervenciones no farmacolgicas para reducir sntomas depresivos en mujeres con cncer de mama

Intervenciones no farmacolgicas para reducir sntomas depresivos en mujeres con cncer de mama

... 11. Kiecolt-Glaser JK, Bennett JM, Andridge R, Peng J, Shapiro CL, Malarkey WB, et al. Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: A randomized controlled trial. J Clin ...

10

Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes

Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes

... Metastatic breast cancer (MBC) remains a largely incura- ble disease causing more than 40,000 deaths in the US alone every year ...of breast cancer ...with metastatic disease ...

10

Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis

Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis

... the metastatic tumor is known to differ between primary tumor and heteroge- neous metastasis ...that breast cancer methylation profiling might yield biomark- ers for the diagnosis and treatment ...

9

Familial Breast Cancer in Costa Rica: An initial approach

Familial Breast Cancer in Costa Rica: An initial approach

... American Cancer Society calculates 215 990 new cases of breast cancer occurring among women in 2004, and estimates 40 580 deaths due to breast cancer within the popula- tion of the ...

6

Breast cancer epidemiology: mammographic screening and molecular subtypes

Breast cancer epidemiology: mammographic screening and molecular subtypes

... of breast cancer molecular breast cancer subtypes defined by IHC biomarkers; and 3) breast cancer survival according to method of ...of breast cancer epidemiology, ...

148

Carcinoma of the breast occurring during pregnancy

Carcinoma of the breast occurring during pregnancy

... eventual placental endocrine stimulus, which we think should be avoided. 2.-During pregnancy, blood supply increases in the mammary ['lands. It is known that blood suppIy varies with activity, being mtlch greater in an ...

18

Docetaxel en el cáncer de próstata avanzado hormonosensible; Informe de evaluación GENESIS-SEFH

Docetaxel en el cáncer de próstata avanzado hormonosensible; Informe de evaluación GENESIS-SEFH

... CHAARTED es un ensayo fase III, multicéntrico, abierto, en el que se alea- torizaron 790 pacientes con diagnóstico reciente de cáncer de próstata metastásico a recibir 6 ciclos de docetaxel más ADT o a recibir la ADT ...

9

Structural elucidation and evaluation of multidrug-resistance modulatory capability of amarissinins A–C, diterpenes derived from Salvia amarissima

Structural elucidation and evaluation of multidrug-resistance modulatory capability of amarissinins A–C, diterpenes derived from Salvia amarissima

... Three new diterpenes (amarissinins A-C, 1-3) containing several oxygenated functionalities were isolated from the leaves and flowers of Salvia amarissima. The structures of these compounds were established through the ...

27

Social inequalities and mortality in Europe-results from a large multi-national cohort

Social inequalities and mortality in Europe-results from a large multi-national cohort

... of Cancer Epidemiology and Prevention, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland, 8 Division of Clinical Epidemiology, German Cancer Research Centre, Heidelberg, ...

10

Endocrine disruptors as ligands of breast cancer proteins

Endocrine disruptors as ligands of breast cancer proteins

... This study presents a virtual screening that helps to understand how endocrine disruptors could be plausible ligands for the breast cancer proteome. This approach provided important candidates to be ...

175

La cronoterapia en el tratamiento de enfermedades oncológicas

La cronoterapia en el tratamiento de enfermedades oncológicas

... for Metastatic Colorectal Cancer” en su estudio de cohortes analizan la pérdida de peso y la fatiga en pacientes con cáncer de colon metastásico, llegando a la conclusión de que si se producen estos efectos ...

40

Invasive breast cancer  Clinical, molecular and genetic aspects

Invasive breast cancer Clinical, molecular and genetic aspects

... La edad promedio en que se diagnostica está en- tre los 58 y los 63 años de edad, a pesar de que el hombre puede desarrollar la condición a cualquier edad. El envejecimiento, la atrofia testicular, la infer- tilidad, una ...

27

Estudio de adherencia y seguridad en pacientes a tratamiento con capecitabina

Estudio de adherencia y seguridad en pacientes a tratamiento con capecitabina

... (breast cancer, colorectal cancer, gas- tric cancer, off-label), adherence (tablet count, Morisky test, Sackett test), safety (assessment of adverse events, clinical evaluation by the ...

18

Genetic Cancer Risk Assessment for Breast Cancer in Latin America

Genetic Cancer Risk Assessment for Breast Cancer in Latin America

... genetic cancer program in the coun- try, which serves as a referral center for patients with cancer diagnosis and their families ...nationwide. Cancer genetic training and genetic testing have been ...

9

Key words: Breast cancer, detection, mammography,

Key words: Breast cancer, detection, mammography,

... solid breast masses: re- trospective single- and multimodality evaluation of 201 ...al., Breast Imaging Reporting and Data System (BI-RADS), ACR, 2003, Fourth Edition • ...in breast cancer ...

16

Show all 1450 documents...

Related subjects